Ying Huang
Directeur Général chez LEGEND BIOTECH CORPORATION
Fortune : 3 M $ au 31/05/2024
Profil
Actuellement, Ying Huang occupe le poste de directeur exécutif et financier de Legend Biotech Corp. Au cours de sa carrière, M. Huang a occupé les postes de scientifique principal chez Schering-Plough Corp, d'analyste de recherche chez Credit Suisse Securities (USA) LLC (courtier), d'analyste associé chez Wachovia Securities LLC, de vice-président et d'analyste principal chez Barclays Capital, Inc. et d'analyste de recherche chez Merrill Lynch, Pierce, Fenner & Smith, Inc. et chez Gleacher & Co. Securities, Inc. M. Huang est titulaire d'un doctorat et d'un diplôme d'études supérieures de The Trustees of Columbia University in The City of New York et d'un diplôme de premier cycle de l'Université des sciences et technologies de Chine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LEGEND BIOTECH CORP.
0,04% | 31/12/2023 | 128 492 ( 0,04% ) | 3 M $ | 31/05/2024 |
Postes actifs de Ying Huang
| Sociétés | Poste | Début |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Directeur Général | 21/09/2020 |
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Directeur/Membre du Conseil | 01/02/2022 |
Anciens postes connus de Ying Huang
| Sociétés | Poste | Fin |
|---|---|---|
BofA Securities, Inc.
 BofA Securities, Inc. Investment Banks/BrokersFinance BofA Securities, Inc. is a registered broker-dealer subsidiary of NB Holdings Corp., ultimately held by Bank of America Corp. (NYSE: BAC). Headquartered in New York, the firm was founded in 2015 and offers trade execution, trading or brokerage services to institutional clients. | Corporate Officer/Principal | 01/07/2019 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Analyst-Equity | 13/05/2019 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Analyst-Equity | 31/07/2014 |
Gleacher & Co. Securities, Inc.
 Gleacher & Co. Securities, Inc. Investment Banks/BrokersFinance Gleacher & Co. Securities, Inc. is an investment banking, capital markets and brokerage firm located in New York City. They are a subsidiary of Gleacher & Co., Inc. (NasdaqGM: GLCH). The firm was formerly known as Broadpoint Capital and was formed in 2010 as the result of the merger of merger of Broadpoint.Amtech Equity Capital Markets and Broadpoint.Gleacher Securities. Gleacher & Co. Securities provides corporate and public finance services and trading of corporate, government and municipal securities for institutional investors. The firm has three divisions: Municipal Capital Markets, Taxable Fixed-Income and Equity Capital Markets. The Municipal Capital Markets division underwrites and trades municipal securities in new issue and secondary markets. The Taxable Fixed-Income division is a broker/dealer that focuses on fixed-income securities with limited liquidity. The Equity Capital Markets division is a sector-focused investment banking group that provides research, trading, capital raising and advisory services to institutional and corporate clients. Gleacher & Co. Securities provides research on hundreds of equity, fixed-income and mortgage/asset backed securities. The firm offers research and execution services on thousands of securities across a full spectrum of industry sectors and asset classes. | Analyst-Equity | - |
Formation de Ying Huang
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Science & Technology of China | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LEGEND BIOTECH CORPORATION | Health Technology |
| Entreprise privées | 8 |
|---|---|
Wachovia Securities LLC
 Wachovia Securities LLC Investment Banks/BrokersFinance Wachovia Securities LLC offered equity, fixed income, and structured products. It was founded in 2001 and was headquartered in St. Louis, MO. | Finance |
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Finance |
Gleacher & Co. Securities, Inc.
Gleacher & Co. Securities, Inc. Investment Banks/BrokersFinance Gleacher & Co. Securities, Inc. is an investment banking, capital markets and brokerage firm located in New York City. They are a subsidiary of Gleacher & Co., Inc. (NasdaqGM: GLCH). The firm was formerly known as Broadpoint Capital and was formed in 2010 as the result of the merger of merger of Broadpoint.Amtech Equity Capital Markets and Broadpoint.Gleacher Securities. Gleacher & Co. Securities provides corporate and public finance services and trading of corporate, government and municipal securities for institutional investors. The firm has three divisions: Municipal Capital Markets, Taxable Fixed-Income and Equity Capital Markets. The Municipal Capital Markets division underwrites and trades municipal securities in new issue and secondary markets. The Taxable Fixed-Income division is a broker/dealer that focuses on fixed-income securities with limited liquidity. The Equity Capital Markets division is a sector-focused investment banking group that provides research, trading, capital raising and advisory services to institutional and corporate clients. Gleacher & Co. Securities provides research on hundreds of equity, fixed-income and mortgage/asset backed securities. The firm offers research and execution services on thousands of securities across a full spectrum of industry sectors and asset classes. | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Finance |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Finance |
BofA Securities, Inc.
BofA Securities, Inc. Investment Banks/BrokersFinance BofA Securities, Inc. is a registered broker-dealer subsidiary of NB Holdings Corp., ultimately held by Bank of America Corp. (NYSE: BAC). Headquartered in New York, the firm was founded in 2015 and offers trade execution, trading or brokerage services to institutional clients. | Finance |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Health Technology |
